We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

Molecular Test Finds Increased Chikungunya Virus Infections

By LabMedica International staff writers
Posted on 24 Sep 2014
Print article
Image: Digitally-colorized transmission electron micrograph (TEM) depicts numerous Chikungunya virus particles, which are composed of a central dense core that is surrounded by a viral envelope. Each virion is approximately 50 nm in diameter (Photo courtesy of Cynthia Goldsmith).
Image: Digitally-colorized transmission electron micrograph (TEM) depicts numerous Chikungunya virus particles, which are composed of a central dense core that is surrounded by a viral envelope. Each virion is approximately 50 nm in diameter (Photo courtesy of Cynthia Goldsmith).
Chikungunya is an infectious disease that causes fever, rash, and for a subset of patients, chronic joint pain. Pregnant women who acquire Chikungunya infection within one week of delivery can transmit the virus to their baby, which can lead to severe infection.

Clinical laboratory testing for Chikungunya virus may involve molecular reverse transcription polymerase chain reaction (RT-PCR), which identifies the ribonucleic acid (RNA) of the virus and immunoassays, which assess blood-serum levels of the antibodies Immunoglobulin M and G (IgM and IgG).

Medial experts from Focus Diagnostics (Cypress, CA, USA) analyzed de-identified clinical results of RT-PCR and IgG/IgM tests for Chikungunya ordered by clinicians between January 1 and August 2, 2014. The investigators determined that 2,947 patient samples were tested for antibodies to the virus by Focus Diagnostics clinical laboratory between January 1 and August 2, 2014. Of this total, 82% (2,402) were tested in June and July, suggesting a surge in test volume over the summer. Another 589 RT-PCR tests were also performed on patients. Eighty-eight specimens tested by both methods were ordered and performed.

About 22% of the total tested for antibodies, were IgG and/or IgM positive, suggesting a diagnosis of Chikungunya. Most patients underwent antibody testing well after initial infection. Sixteen percent of specimens exhibited an IgG positive/IgM positive antibody pattern, compared to 5% of specimens that were IgG negative/IgM positive. In addition, the rate of IgG/IgM positive specimens increased since June. These findings suggest that most patients were tested well after initial infection with the virus.

The investigators also determined that of 589 specimens tested by RT-PCR, 168 (28%) were positive for the Chikungunya virus. All positive PCR tests were performed during or after April 2014, possibly because of increased awareness of Chikungunya infection and PCR's role in diagnosing early infection. RT-PCR is helpful for detecting the virus within the first week of infection, but less reliably afterwards.

Hollis Batterman, MD, the medical director at Focus Diagnostics, said, “Our findings suggest that PCR and antibody testing should be considered in anyone with a compatible clinical syndrome who has traveled to or lives in areas with the species of mosquitos that carry the virus. The majority of seropositive samples were IgG/IgM positive, suggesting that most patients were tested later in the onset of infection. In the absence of PCR testing, antibody IgG/IgM patterns may be useful to infer onset of illness, and potential risk of transmission if bitten by mosquitoes.” The study was presented at the 54th Interscience Conference on Antimicrobial Agents and Chemotherapy held September 5–9, 2014, in Washington DC (USA).

Related Links:

Focus Diagnostic 


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.